[Form 4] Solventum Corporation Insider Trading Activity

Rhea-AI Filing Summary

Solventum Corp reporting person 3M Co. disclosed an insider sale of 8,800,000 shares of common stock on 08/15/2025 at $73.45 per share, reducing the reporting person’s beneficial ownership to 25,569,190 shares. The Form 4 indicates the filer is a director and the filing was signed on 08/18/2025. No derivative transactions or additional explanatory narrative were provided.

Positive

• Substantial residual ownership: Reporting person still beneficially owns 25,569,190 shares, indicating material ongoing stake.

Negative

• Large insider sale: Disposition of 8,800,000 shares at $73.45 on 08/15/2025, which could be perceived negatively absent explanation.

Insights

Corporate Governance Expert

TL;DR: A significant insider sale occurred, which merits attention but the reporting person retains a large residual stake.

The Form 4 shows a substantial open-market or private disposition of 8.8 million shares at $73.45, a meaningful sale by a director. Such sales can reflect liquidity needs or portfolio rebalancing rather than a change in confidence, but absent narrative the market must interpret the sale on its face. The reporting person still holds 25,569,190 shares, indicating continued material ownership and alignment with shareholders.

Securities Analyst

TL;DR: Material quantity sold but no derivatives or plans disclosed; remaining stake remains sizeable.

The filing records only a non-derivative disposition. There are no listed derivatives, no execution plan disclosure, and no price/volume context beyond the single trade price of $73.45. From an investor-information perspective, the transaction is material in size but lacks contextual details that would clarify intent or signaling value.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

3M CO

(Last) (First) (Middle)

3M CENTER

(Street)

ST. PAUL MN 55144

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Solventum Corp [ SOLV ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
08/15/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/15/2025		S		8,800,000	D	$73.45	25,569,190	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	/s/ Kevin H. Rhodes, Secretary	08/18/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did the Form 4 for SOLV report?

The Form 4 reports a sale of 8,800,000 Solventum (SOLV) common shares at $73.45 per share on 08/15/2025 by 3M Co., a director.

How many SOLV shares does the reporting person own after the sale?

Following the reported transaction the reporting person beneficially owns 25,569,190 shares.

Was any derivative or option transaction reported in this Form 4?

No. Table II for derivative securities contains no reported transactions; only a non-derivative disposition is listed.

Does the filing explain the reason for the sale or indicate a Rule 10b5-1 plan?

No explanatory text or indication of a 10b5-1 trading plan is included in the provided Form 4 content.

Who signed the Form 4 and when?

The Form 4 was signed by /s/ Kevin H. Rhodes, Secretary on 08/18/2025.